1996
DOI: 10.1007/bf00144429
|View full text |Cite
|
Sign up to set email alerts
|

A new method of antibiotyping yeasts for subspecies discrimination and distribution in human clinical specimens

Abstract: A study of the antibiotypes of 764 isolates of the genera Candida and Torulopsis from different clinical specimens is reported. The typing method was based on the susceptibility results obtained by the standardized and partially automated kit ATB-Fungus (API-bioMérieux), giving to each strain a code of six figures, according to these criteria: susceptibility to 5-fluorocytosine, amphotericin B, nystatin, miconazole, econazole, and ketoconazole. Candida albicans serotypes were determined by the Candida Check te… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1997
1997
2000
2000

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 33 publications
(56 reference statements)
0
2
0
Order By: Relevance
“…The conclusion of the authors of this latter study was that although this biotyping method was effective for research applications, it probably would not prove effective for clinical use. In addition to serotyping and the Odds and Abbott biotyping method, a number of other biotyping methods have been used to discriminate C. albicans strains, including morphotyping (145,270,293), resistotyping (144,215), killer yeast typing (278,279), enzyme typing (66,424,425), sugar assimilation typing (50,105,113,120) and drug susceptibility typing (294). Isoenzyme biotyping has also been successfully applied to Candida species (52,180,288).…”
Section: Biotyping Is Inadequate As a Dna Fingerprinting Methodsmentioning
confidence: 99%
“…The conclusion of the authors of this latter study was that although this biotyping method was effective for research applications, it probably would not prove effective for clinical use. In addition to serotyping and the Odds and Abbott biotyping method, a number of other biotyping methods have been used to discriminate C. albicans strains, including morphotyping (145,270,293), resistotyping (144,215), killer yeast typing (278,279), enzyme typing (66,424,425), sugar assimilation typing (50,105,113,120) and drug susceptibility typing (294). Isoenzyme biotyping has also been successfully applied to Candida species (52,180,288).…”
Section: Biotyping Is Inadequate As a Dna Fingerprinting Methodsmentioning
confidence: 99%
“…The conclusion of the authors of this latter study was that although this biotyping method was effective for research applications, it probably would not prove effective for clinical use. In addition to serotyping and the Odds and Abbott biotyping method, a number of other biotyping methods have been used to discriminate C. albicans strains, including morphotyping (145,270,293), resistotyping (144,215), killer yeast typing (278,279), enzyme typing (66,424,425), sugar assimilation typing (50,105,113,120) and drug susceptibility typing (294). Isoenzyme biotyping has also been successfully applied to Candida species (52,180,288).…”
Section: Biotyping Is Inadequate As a Dna Fingerprinting Methodsmentioning
confidence: 99%